Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MERCK SHARP & DOHME CORP. et al v. SANDOZ INC.
Case Number:
2:12-cv-06077
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 09, 2013
Sandoz Agrees To Shelve Plans For Generic Zetia
Generic-drug maker Sandoz Inc. on Monday agreed not to make, sell or distribute a version of Merck & Co. Inc.'s anti-cholesterol drug Zetia until 2017, putting to rest Merck's patent infringement suit.
-
October 02, 2012
Merck Sues To Block Sandoz's Generic Zetia
Units of Merck & Co. Inc. on Thursday hit generics maker Sandoz Inc. with a patent infringement suit in New Jersey federal court in their latest effort to block generic versions of the anti-cholesterol drug Zetia.